Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

32.07
+0.44001.39%
Post-market: 32.150.0791+0.25%17:47 EDT
Volume:3.22M
Turnover:103.98M
Market Cap:3.60B
PE:-27.81
High:32.75
Open:32.20
Low:31.92
Close:31.63
Loading ...
Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 27, 2025

Major Issues Report

Form 8-K - Current report
Apr 24, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 23, 2025

Major Issues Report

Form 8-K - Current report
Apr 23, 2025

Major Issues Report

Form 8-K - Current report
Apr 09, 2025

Correspondence

Form CORRESP - Correspondence
Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Feb 26, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 05, 2025

Major Issues Report

Form 8-K - Current report
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Proposed Sale Of Securities

Form 144 | VIKING THERAPEUTICS, INC. Director Lawson Macartney proposes to sell 2000 shares, with a total value of approximately $137,334.
Nov 04, 2024

Major Issues Report

Form 8-K - Current report
Oct 28, 2024

Proposed Sale Of Securities

Form 144 | Viking Therapeutics' Officer Greg Zante proposes to sell 131,687 Shares, with a total value of approximately $10.28 Million.
Oct 25, 2024

Proposed Sale Of Securities

Form 144 | Viking Therapeutics' Director Rouan Sarah Kathryn proposes to sell 11,000 shares, with a total value of approximately $889,430.
Oct 25, 2024

Proposed Sale Of Securities

Form 144 | Viking Therapeutics' Director Singleton proposes to sell 16000 shares, with a total value of approximately $1.27 Million.